Christa Corley
Researcher
Also affiliated: Tougaloo College (2016); University of Kentucky (2024–2026); Loyola University Chicago (2025)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Christa Corley's research investigates the physiological and cognitive impacts of various medical treatments, particularly chemotherapy and irradiation, in preclinical models. Her work has explored the effects of 5-fluorouracil/leucovorin chemotherapy and fractionated proton irradiation on cognitive function in mice, examining memory and behavior. Corley has also studied the implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal cognition and the gut microbiome, as well as the potential of tocotrienols as an anti-breast cancer agent. Additionally, her research has addressed nicotine's role as an immunosuppressant with implications for women's health. She has published 19 works, with 124 citations, and maintains collaborations with researchers at the University of Arkansas for Medical Sciences, including Antiño R. Allen, Pilar Simmons, Michael S. Robeson, and Sangam Kandel.
Metrics
- h-index: 8
- Publications: 20
- Citations: 131
Selected Publications
-
Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment (2026)
-
Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome (2025)
-
Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior (2023)
-
Fractionated Proton Irradiation Does Not Impair Hippocampal-Dependent Short-Term or Spatial Memory in Female Mice (2022)
-
The Effects of 5-Fluorouracil/Leucovorin Chemotherapy on Cognitive Function in Male Mice (2021)
-
Tocotrienols as an Anti-Breast Cancer Agent (2021)
-
A Bibliometric Analysis of Cyclophosphamide, Methotrexate, and Fluorouracil Breast Cancer Treatments: Implication for the Role of Inflammation in Cognitive Dysfunction (2021)
-
Cranial irradiation impairs juvenile social memory and modulates hippocampal physiology (2020)
Collaboration Network
Top Collaborators
- Tocotrienols as an Anti-Breast Cancer Agent
- A Bibliometric Analysis of Cyclophosphamide, Methotrexate, and Fluorouracil Breast Cancer Treatments: Implication for the Role of Inflammation in Cognitive Dysfunction
- The Effects of 5-Fluorouracil/Leucovorin Chemotherapy on Cognitive Function in Male Mice
- Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
- Fractionated Proton Irradiation Does Not Impair Hippocampal-Dependent Short-Term or Spatial Memory in Female Mice
Showing 5 of 7 shared publications
- Tocotrienols as an Anti-Breast Cancer Agent
- Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
- Fractionated Proton Irradiation Does Not Impair Hippocampal-Dependent Short-Term or Spatial Memory in Female Mice
- Tocotrienols as an Anti-Breast Cancer Agent
- Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
- Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
- Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome
- Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
- Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
- Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome
- Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
- Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome
- Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment
- Tocotrienols as an Anti-Breast Cancer Agent
- The Effects of 5-Fluorouracil/Leucovorin Chemotherapy on Cognitive Function in Male Mice
- The Effects of 5-Fluorouracil/Leucovorin Chemotherapy on Cognitive Function in Male Mice
- Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
- Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior
- Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome
- Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome
Similar Researchers
Based on overlapping research topics